Risk-reducing mastectomy cost-effective for women aged 30 to 55 years with lifetime breast cancer risk of 35 percent or higher.

Reducing PSA-based screening appears to have contributed to delayed detection and management of aggressive prostate cancer.

Inhibiting S100A9 or blocking TLR4/RAGE receptors impairs ETV5-mediated recruitment of suppressive myeloid cells in HCC.

Younger cancer survivors were more likely than their older peers to start alcohol use disorder treatment within 1 year of diagnosis. Less than 15% of cancer survivors diagnosed with alcohol use ...

New research suggests that pediatric patients with diffuse midline gliomas may have better outcomes if they have a more diverse gut microbiome.

In the APOLLO trial, first-line treatment with anlotinib plus penpulimab improved progression-free survival and overall survival when compared to sorafenib.

No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users.

Researchers conducted a concept analysis of processing speed in relation to the cognitive function of patients with cancer.

A PedCST designed for pediatric oncology nurses and an interactive e-picture book application for pediatric patients and their parents improved QOL and emotional well-being for children with cancer.

The authors concluded that even mild 18 F-FDG uptake may indicate the presence of lymphoma in areas of the brain where the blood-brain barrier is intact. They recommended clinicians be suspicious of ...

The supplemental Biologics License Application for the gastric/GEJ cancer indication is supported by data from the double-blind, placebo-controlled MATTERHORN trial.

These findings suggest a need to investigate whether age-specific trends are due to guidelines that suggest reduced screening for older age groups,” the researchers wrote.